Neuronal ceroid lipofuscinosis: diagnostic algorithm and clinical description of the variants late infantile Finnish (CLN5) and Turkish (CLN7)

被引:4
|
作者
del Socorro Perez-Poyato, Maria [1 ]
Mila-Recasens, Montserrat [4 ,6 ]
Ferrer-Abizanda, Isidre [5 ]
Cusi-Sanchez, Victoria [2 ]
Vazquez-Lopez, Maria [7 ]
Camino-Leon, Rafael [8 ]
Josep Coll-Rosell, M. [3 ,6 ]
Gort, Laura [3 ,6 ]
Pineda-Marfa, Merce [1 ,6 ]
机构
[1] Hosp St Joan de Deu, Serv Neurol Pediat, Barcelona, Spain
[2] Hosp St Joan de Deu, Serv Anat Patol, Barcelona, Spain
[3] Univ Barcelona, Hosp Clin, IDIBAPS, Secc Errores Innatos Metab,IBC, Barcelona, Spain
[4] Univ Barcelona, Hosp Clin, IDIBAPS, Serv Bioquim & Genet Mol, Barcelona, Spain
[5] Hosp Univ Bellvitge, Inst Neuropatol, Serv Anat Patol, IDIBELL, Barcelona, Spain
[6] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, CIBER ER, Madrid, Spain
[7] Hosp Gen Gregorio Maranon, Serv Neurol Pediat, Madrid, Spain
[8] Hosp Reina Sofia, Unidad Neurol Pediat, Cordoba, Spain
关键词
Algorithm; Clinical course; CLN5; CLN7; Finnish and Turkish variants; Neuronal ceroid lipofuscinosis; JANSKY-BIELSCHOWSKY DISEASE; MUTATIONS; JUVENILE; NCL; PHENOTYPE; GENOTYPE; FREQUENT; UPDATE; ONSET;
D O I
10.33588/rn.5409.2011657
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The neuronal ceroid lipofuscinosis are classified based on age at onset into four main clinical forms in childhood: infantile, late infantile, juvenile and congenital (CLN1, CLN2, CLN3 and CLN10). The variant late infantile forms (CLN5, CLN6, CLN7 and CLN8) are characterized by a wide variability of the clinical phenotypes and the most patients are originated from Finland and Turkey (Finnish, CLN5, and Turkish, CLN7 variants). Case reports. We describe three unrelated patients with Finnish variant and another patient with Turkish variant. We describe an algorithm to facility the diagnosis of these low prevalence diseases. Patients with Finnish variant started with behaviour disorder between 2.6 and 4.6 years of age followed by learning difficulties and visual failure at an age of 6 years. Generalised tonic-clonic and myoclonic seizures were observed at 7 years of age with myoclonic jerks later on. Patients developed ataxia and blindness within 9 years and increasingly disability at 11 years of age. The patient with Turkish variant started with refractory epilepsy at age of 2, followed by a severe neurodegeneration manifested by ataxia, loss of walking ability within 2-3 years and vegetative state at 11 years of age. Conclusions. The clinical spectrum of the variant late infantile forms shows a wide geographical distribution. We report three novel mutations in the CLN5 gene and a diagnostic algorithm to facility the correlation genotype-phenotype studies.
引用
收藏
页码:544 / 550
页数:7
相关论文
共 50 条
  • [41] Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL
    von Schantz, Carina
    Kielar, Catherine
    Hansen, Stine N.
    Pontikis, Charlie C.
    Alexander, Noreen A.
    Kopra, Outi
    Jalanko, Anu
    Cooper, Jonathan D.
    NEUROBIOLOGY OF DISEASE, 2009, 34 (02) : 308 - 319
  • [42] CLN6 p.I154del Mutation Causing Late Infantile Neuronal Ceroid Lipofuscinosis in a Large Consanguineous Moroccan Family
    Bouhouche, Ahmed
    Regragui, Wafae
    El Fahime, Elmostafa
    Bouslam, Naima
    Tazi-Ahnini, Rachid
    Melloul, Marouane
    Benomar, Ali
    Yahyaoui, Mohamed
    INDIAN JOURNAL OF PEDIATRICS, 2013, 80 (08) : 694 - 696
  • [43] A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs
    Villani, Natalie A.
    Bullock, Garrett
    Michaels, Jennifer R.
    Yamato, Osamu
    O'Brien, Dennis P.
    Mhlanga-Mutangadura, Tendai
    Johnson, Gary S.
    Katz, Martin L.
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (01) : 107 - 115
  • [44] Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
    Nickel, Miriam
    Simonati, Alessandro
    Jacoby, David
    Lezius, Susanne
    Kilian, Dirk
    Van de Graaf, Benjamin
    Pagovich, Odelya E.
    Kosofsky, Barry
    Yohay, Kaleb
    Downs, Matthew
    Slasor, Peter
    Aiayi, Temitayo
    Crystal, Ronald G.
    Kohlschuetter, Alfried
    Sondhi, Dolan
    Schulz, Angela
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (08) : 582 - 590
  • [45] Novel mutations in CLN6 cause late-infantile neuronal ceroid lipofuscinosis without visual impairment in two unrelated patients
    Chin, Joseph J.
    Behnam, Babak
    Davids, Mariska
    Sharma, Prashant
    Zein, Wadih M.
    Wang, Camille
    Chepa-Lotrea, Xenia
    Gallantine, William Brian
    Toro, Camilo
    Adams, David R.
    Tifft, Cynthia J.
    Gahl, William A.
    Malicdan, May Christine, V
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : 188 - 195
  • [46] Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Katz, Martin L.
    Coates, Joan R.
    Sibigtroth, Christine M.
    Taylor, Jacob D.
    Carpentier, Melissa
    Young, Whitney M.
    Wininger, Fred A.
    Kennedy, Derek
    Vuillemenot, Brian R.
    O'Neill, Charles A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (11) : 1591 - 1598
  • [47] Cln1-mutations suppressRab7-RILPinteraction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis
    Sarkar, Chinmoy
    Sadhukhan, Tamal
    Bagh, Maria B.
    Appu, Abhilash P.
    Chandra, Goutam
    Mondal, Avisek
    Saha, Arjun
    Mukherjee, Anil B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (05) : 1082 - 1101
  • [48] Protein Product of CLN6 Gene Responsible for Variant Late-Onset Infantile Neuronal Ceroid Lipofuscinosis Interacts with CRMP-2
    Benedict, Jared W.
    Getty, Amanda L.
    Wishart, Thomas M.
    Gillingwater, Thomas H.
    Pearce, David A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (09) : 2157 - 2166
  • [49] CLN6 p.I154del Mutation Causing Late Infantile Neuronal Ceroid Lipofuscinosis in a Large Consanguineous Moroccan Family
    Ahmed Bouhouche
    Wafae Regragui
    Elmostafa El Fahime
    Naima Bouslam
    Rachid Tazi-Ahnini
    Marouane Melloul
    Ali Benomar
    Mohamed Yahyaoui
    The Indian Journal of Pediatrics, 2013, 80 : 694 - 696
  • [50] A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase
    Ezaki, J
    Tanida, I
    Kanehagi, N
    Kominami, E
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) : 2573 - 2582